Description

PKCβII Peptide Inhibitor I is a PKCβII inhibitor. PKCβII Peptide Inhibitor I shows cardioprotective effects in rat cardiac Ischemia/reperfusion injury model. PKCβII Peptide Inhibitor I also prevents vascular endothelial dysfunction[1].—–C61H94N12O19—-[1]Omiyi D, et al. Protein kinase C betaII peptide inhibitor exerts cardioprotective effects in rat cardiac ischemia/reperfusion injury. J Pharmacol Exp Ther. 2005 Aug;314(2):542-51.–862502-26-9–1299.47—-O=C([C@H]1N(CCC1)C([C@H](CC(N)=O)NC([C@H](CC(C)C)NC([C@H](CO)NC(CCCCCCCCCCCCC)=O)=O)=O)=O)N[C@@H](CCC(O)=O)C(N[C@H](C(N[C@@H](CC(N)=O)C(N[C@@H](CCC(O)=O)C(N[C@H](C(O)=O)[C@H](O)C)=O)=O)=O)CC2=CNC3=CC=CC=C23)=O–Inflammation/Immunology–10 mM in DMSO–PKC—-Epigenetics;TGF-beta/Smad–Peptides